SWOG clinical trial number
SWOG-7639
Two Adriamycin, Mitomycin-C and 5-Fluorouracil Com- bination in the Management of Gastric Adenocarcinoma
Closed
Abbreviated Title
Two Adriamycin, Mitomycin-C and 5-Fluorouracil Com- bination in the Management of Gastric Adenocarcinoma
Activated
02/15/1977
Closed
01/17/1979
Publication Information Expand/Collapse
1984
Drug combinations in the treatment of gastric adenocarcinoma: A Southwest Oncology Group study.
1980
Southwest Oncology Group experience with two different schedules of 5-FU, Adriamycin and Mitomycin C (FAM) in the management of gastric carcinoma.
1979
Experiences with two treatment schedules in the combination chemotherapy of advanced gastric carcinoma.
Comparison of two different combination of Adriamycin, mitomycin-C and 5-FU in the treatment of gastric carcinoma.